Cardiovascular disease (CVD) accounts for a quarter of all deaths in the UK, but is largely preventable through lifestyle modification and lipid-lowering therapy. The main aim of lipid modification is to reduce low density lipoprotein cholesterol (LDL-C)/non-high density lipoprotein cholesterol (non-HDL-C) which will in turn reduce CVD risk.